IPO: Verve Therapeutics Takes On Cardiovascular Disease Using Gene Editing

IPO: Verve Therapeutics Takes On Cardiovascular Disease Using Gene Editing

Verve Therapeutics, a biotech company innovating new approaches to the care of cardiovascular disease with single-course gene editing medicines, announced terms for its $201 million IPO on today. Insiders Wellington Management and Casdin Capital and new investor Fidelity have indicated an interest in purchasing up to an aggregate $75 million worth of shares in the … Read more

Liquid Biopsy Rapidly Moves From Companion Diagnostic To A Cancer Screening Tool

Liquid Biopsy Rapidly Moves From Companion Diagnostic To A Cancer Screening Tool

In October 2020, the Food and Drug Administration (FDA) approved two blood tests, known as liquid biopsies, that can help guide treatment decisions for people with cancer. The tests, Guardant360 CDx and FoundationOne Liquid CDx, are made by different companies and were approved separately. Doctors have traditionally based treatment decisions on features like the organ … Read more

DARPA Dive: Nucleic acids On-demand Worldwide (NOW)

DARPA Dive: Nucleic acids On-demand Worldwide (NOW)

The Defense Advanced Research Projects Agency (DARPA), established in 1958, is an agency within the Department of Defense (DOD) responsible for catalyzing the development of technologies that maintain and advance the capabilities and technical superiority of the U.S. military. In short, it’s the way the U.S. military tries to prevent technical surprise. The Nucleic acids … Read more

Bacteriophage Therapy Research Gets Boost From NIH

Bacteriophage Therapy Research Gets Boost From NIH

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded $2.5 million in grants to 12 institutes around the world to support research on bacteriophage therapy. These awards represent NIAID’s first series of grants focused exclusively on research on this therapy, an emerging field that could yield … Read more

China’s Biotheus Advances Biologics Therapies With New Financing

China’s Biotheus Advances Biologics Therapies With New Financing

Founded in 2018, Biotheus is a Zhuhai, China-based clinical development stage company with the mission of treating cancer and autoimmune diseases through next-generation therapeutics. The company’s product pipeline consists of over ten novel monoclonal and multispecific antibodies focused on curing malignant tumors and autoimmune diseases. Biotheus currently has two bispecific antibodies in phase I clinical … Read more

Dr. Eric Lander, The Synthetic Biology Cabinet Member

Dr. Eric Lander, The Synthetic Biology Cabinet Member

Since taking office in January, President Joe Biden has reaffirmed a national commitment to integrity in scholarship and research, appointing scientists to numerous leadership roles.   Educators and experts applaud these appointments and say elevating intellectual integrity in research and science will take the combined effort of universities, industry and the public, too.     Biden appointed Eric … Read more

VoiceRPA Is Coming To Healthcare With Infinitus

VoiceRPA Is Coming To Healthcare With Infinitus

Infinitus is a voice robotic process automation (VoiceRPA) company that is targeting the complexity and cost in U.S. healthcare. Another player in the healthcare robotic process automation (RPA) arena just completed a large capital raise. These RPA companies are bringing enterprise cloud/SaaS dynamism towards a much-needed re-platforming of the ailing and inefficient U.S. healthcare industry. … Read more

Strand Therapeutics Aims For Genetically-Programed RNA

Strand Therapeutics Aims For Genetically-Programed RNA

Strand Therapeutics, a private company based in Massachusetts, is building a platform based on technology developed by biological engineers at MIT including scientific co-founders, Professor Ron Weiss, Ph.D., a pioneer of the field of synthetic biology, and Professor Darrell J. Irvine, Ph.D., a leading researcher of materials for immune-engineering. The co-founders sought to apply synthetic … Read more